These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21328569)

  • 1. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
    Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
    Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
    Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
    Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent hypersocial behavior in mice carrying a deletion of
    Martin LA; Iceberg E; Allaf G
    Brain Behav; 2018 Jan; 8(1):e00895. PubMed ID: 29568691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile.
    Antonell A; Del Campo M; Magano LF; Kaufmann L; de la Iglesia JM; Gallastegui F; Flores R; Schweigmann U; Fauth C; Kotzot D; Pérez-Jurado LA
    J Med Genet; 2010 May; 47(5):312-20. PubMed ID: 19897463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical 7q11.23 deletions excluding ELN gene result in Williams-Beuren syndrome craniofacial features and neurocognitive profile.
    Alesi V; Loddo S; Orlando V; Genovese S; Di Tommaso S; Liambo MT; Pompili D; Ferretti D; Calacci C; Catino G; Falasca R; Dentici ML; Novelli A; Digilio MC; Dallapiccola B
    Am J Med Genet A; 2021 Jan; 185(1):242-249. PubMed ID: 33098373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An atypical 7q11.23 deletion in a normal IQ Williams-Beuren syndrome patient.
    Ferrero GB; Howald C; Micale L; Biamino E; Augello B; Fusco C; Turturo MG; Forzano S; Reymond A; Merla G
    Eur J Hum Genet; 2010 Jan; 18(1):33-8. PubMed ID: 19568270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular investigation, using chromosomal microarray and whole exome sequencing, of six patients affected by Williams Beuren syndrome and Autism Spectrum Disorder.
    Masson J; Demily C; Chatron N; Labalme A; Rollat-Farnier PA; Schluth-Bolard C; Gilbert-Dussardier B; Giuliano F; Touraine R; Tordjman S; Verloes A; Testa G; Sanlaville D; Edery P; Lesca G; Rossi M
    Orphanet J Rare Dis; 2019 May; 14(1):121. PubMed ID: 31151468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of the N-terminal region of TFII-I in viability and behavior.
    Lucena J; Pezzi S; Aso E; Valero MC; Carreiro C; Dubus P; Sampaio A; Segura M; Barthelemy I; Zindel MY; Sousa N; Barbero JL; Maldonado R; Pérez-Jurado LA; Campuzano V
    BMC Med Genet; 2010 Apr; 11():61. PubMed ID: 20403157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smaller and larger deletions of the Williams Beuren syndrome region implicate genes involved in mild facial phenotype, epilepsy and autistic traits.
    Fusco C; Micale L; Augello B; Teresa Pellico M; Menghini D; Alfieri P; Cristina Digilio M; Mandriani B; Carella M; Palumbo O; Vicari S; Merla G
    Eur J Hum Genet; 2014 Jan; 22(1):64-70. PubMed ID: 23756441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxious, hypoactive phenotype combined with motor deficits in Gtf2ird1 null mouse model relevant to Williams syndrome.
    Schneider T; Skitt Z; Liu Y; Deacon RM; Flint J; Karmiloff-Smith A; Rawlins JN; Tassabehji M
    Behav Brain Res; 2012 Aug; 233(2):458-73. PubMed ID: 22652393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The contribution of GTF2I haploinsufficiency to Williams syndrome.
    Chailangkarn T; Noree C; Muotri AR
    Mol Cell Probes; 2018 Aug; 40():45-51. PubMed ID: 29305905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social, neurodevelopmental, endocrine, and head size differences associated with atypical deletions in Williams-Beuren syndrome.
    Lugo M; Wong ZC; Billington CJ; Parrish PCR; Muldoon G; Liu D; Pober BR; Kozel BA
    Am J Med Genet A; 2020 May; 182(5):1008-1020. PubMed ID: 32077592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a putative transcription factor gene (WBSCR11) that is commonly deleted in Williams-Beuren syndrome.
    Osborne LR; Campbell T; Daradich A; Scherer SW; Tsui LC
    Genomics; 1999 Apr; 57(2):279-84. PubMed ID: 10198167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential functions of the Williams-Beuren syndrome-associated TFII-I genes in embryonic development.
    Enkhmandakh B; Makeyev AV; Erdenechimeg L; Ruddle FH; Chimge NO; Tussie-Luna MI; Roy AL; Bayarsaihan D
    Proc Natl Acad Sci U S A; 2009 Jan; 106(1):181-6. PubMed ID: 19109438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epilepsy is a possible feature in Williams-Beuren syndrome patients harboring typical deletions of the 7q11.23 critical region.
    Nicita F; Garone G; Spalice A; Savasta S; Striano P; Pantaleoni C; Spartà MV; Kluger G; Capovilla G; Pruna D; Freri E; D'Arrigo S; Verrotti A
    Am J Med Genet A; 2016 Jan; 170A(1):148-55. PubMed ID: 26437767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.
    Morris CA; Mervis CB; Hobart HH; Gregg RG; Bertrand J; Ensing GJ; Sommer A; Moore CA; Hopkin RJ; Spallone PA; Keating MT; Osborne L; Kimberley KW; Stock AD
    Am J Med Genet A; 2003 Nov; 123A(1):45-59. PubMed ID: 14556246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.
    Vandeweyer G; Van der Aa N; Reyniers E; Kooy RF
    Am J Hum Genet; 2012 Jun; 90(6):1071-8. PubMed ID: 22608712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal Microarray Analysis in Taiwanese Patients with Williams-Beuren Syndrome.
    Kuo HT; Chen CH; Lin CY; Chang YS; Chang JG
    Cytogenet Genome Res; 2019; 159(4):182-189. PubMed ID: 31931504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A physical map, including a BAC/PAC clone contig, of the Williams-Beuren syndrome--deletion region at 7q11.23.
    Peoples R; Franke Y; Wang YK; Pérez-Jurado L; Paperna T; Cisco M; Francke U
    Am J Hum Genet; 2000 Jan; 66(1):47-68. PubMed ID: 10631136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
    Crespi BJ; Hurd PL
    BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.